Sino Biopharmaceutical | 1177 - Net Income

Stock Price
6.44
Daily Change
0.01 0.16%
Monthly
-5.71%
Yearly
116.84%
Q1 Forecast
6.37

Sino Biopharmaceutical reported CNY3.39B in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
IQVIA Holdings USD 514M 183M Dec/2025
Jiangsu Hengrui CNY 1.3B 1.27B Sep/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025